Skip to Main Content

Author Details

Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
2006
41
30
PMIDPaper TitleJournal TitlePublished Year
35363872Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.Blood Adv2022
33413557NRG1 fusions in breast cancer.Breast Cancer Res2021
34562502Genomic characterization of hepatoid tumors: context matters.Hum Pathol2021
32187361Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.Blood2020
33144218Defining the clinical genomic landscape for real-world precision oncology.Genomics2020
32675551Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.Ann Surg2020
31586074Genetic modification of primary human B cells to model high-grade lymphoma.Nat Commun2019
31665210Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.Ann Oncol2019
28643781Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.Nat Commun2017
28954785The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.Clin Cancer Res2017
25833184Modeling the evolution space of breakage fusion bridge cycles with a stochastic folding process.J Math Biol2016
27615322Mutational signatures of ionizing radiation in second malignancies.Nat Commun2016
27498871Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer.Cell Rep2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25710373Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.PLoS Med2015
24413735RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.Nat Genet2014
25030888C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency.Genome Res2014
25082706Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.Science2014
24633157Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Nat Genet2014
24714652Processed pseudogenes acquired somatically during cancer development.Nat Commun2014
23770606Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.Nat Genet2013
24162739Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.Nat Genet2013
23630320Single-cell paired-end genome sequencing reveals structural variation per cell cycle.Nucleic Acids Res2013
22183581The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer.J Pathol2012
23260012Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.BMC Genomics2012
22505352Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.Genes Chromosomes Cancer2012
22527501Circulating DNA and next-generation sequencing.Recent Results Cancer Res2012
22514011Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes.J Pathol2012
22608084Mutational processes molding the genomes of 21 breast cancers.Cell2012
22608083The life history of 21 breast cancers.Cell2012
21063398Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.Br J Cancer2011
21742554Evolution of platinum resistance in high-grade serous ovarian cancer.Lancet Oncol2011
20581869Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.Oncogene2010
19956657The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.PLoS One2009
18084325Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.Oncogene2008
18840272High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.BMC Cancer2008
18302246Molecular cytogenetic characterization of a unique and complex de novo 8p rearrangement.Am J Med Genet A2008
17973251Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.Genes Chromosomes Cancer2008
17285574Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.Genes Chromosomes Cancer2007
16636668High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.Oncogene2006
  • 1 - 41 of 41

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 18
Human Longevity Inc.
Career Start Year 2012
Number of shared co-authors 22
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 19
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 19
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 6
University of California los angeles
Career Start Year 2008
Number of shared co-authors 16
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 34
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year 2006
Number of shared co-authors 16
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 6
Michelson Center for Convergent Bioscience, University of Southern California
Career Start Year 2004
Number of shared co-authors 6
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 16
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 41
University of California
Career Start Year 2003
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 19
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 14
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 6
Monash University
Career Start Year 2000
Number of shared co-authors 2
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 23
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 13
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 6
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 32
University of Zurich
Career Start Year 1995
Number of shared co-authors 4
Broad Institute
Career Start Year 1983
Number of shared co-authors 20

Collaborators

Wellcome Sanger Institute
Co-authored papers 20
Wellcome Sanger Institute
Co-authored papers 16
Wellcome Sanger Institute
Co-authored papers 14
Wellcome Sanger Institute
Co-authored papers 13
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 13
Wellcome Sanger Institute
Co-authored papers 13
The Francis Crick Institute
Co-authored papers 13
Early Cancer Institute, University of Cambridge
Co-authored papers 11
Wellcome Trust Sanger Institute
Co-authored papers 10
Wellcome Trust Sanger Institute
Co-authored papers 9
Wellcome Sanger Institute
Co-authored papers 9
Co-authored papers 9
Moores Cancer Center, university of california san diego
Co-authored papers 9
Wellcome Sanger Institute
Co-authored papers 8
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
Wellcome Trust Sanger Institute
Co-authored papers 8
Wellcome Sanger Institute
Co-authored papers 7
Wellcome Trust Sanger Institute
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
University College London, UCL Cancer Institute
Co-authored papers 7
Wellcome Sanger Institute
Co-authored papers 7
Wellcome Sanger Institute
Co-authored papers 7
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 6
University of East Anglia
Co-authored papers 6
Inivata Ltd
Co-authored papers 6
University of Bern
Co-authored papers 6
Clinical Research Facility, Mercy University Hospital
Co-authored papers 6
Co-authored papers 5
Wellcome Sanger Institute
Co-authored papers 5